Eli Lilly Ready to Seek Obesity Pill Green Light After Study Hits Goals – The Wall Street Journal

  1. Eli Lilly Ready to Seek Obesity Pill Green Light After Study Hits Goals  The Wall Street Journal
  2. Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval  CNBC
  3. Eli Lilly Says New Pill Results in 10.5% Weight-Loss for Diabetes Patients. The Stock Is Up.  Barron’s
  4. Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity  Eli Lilly and Company
  5. Eli Lilly’s oral GLP-1 pill may help people with Type 2 diabetes lose ‘significant’ weight, study finds  ABC News

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *